ADCT NYSE
ADC Therapeutics S.A.
1W: +1.8%
1M: -16.4%
3M: -16.6%
YTD: -2.8%
1Y: +59.1%
3Y: +40.2%
5Y: -83.9%
$3.39
-0.01 (-0.29%)
Weekly Expected Move ±5.5%
$3
$3
$3
$3
$4
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$79M
Revenue
+4.4% YoY
$-137M
Net Income
+8.6% YoY
$-115M
Free Cash Flow
+16.2% YoY
82.7%
Gross Margin
-121.1%
Op. Margin
-158.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE70.5%
ROA-42.5%
ROIC1146.9%
Valuation
P/E-3.8
P/B-2.4
EV/EBITDA-8.6
Leverage
Debt/Equity-2.36
Current Ratio4.37
Interest Cov.-1.7x
Quality Scores
Piotroski F5/9
Altman Z-6.19
Beneish M10.03